Time to Go All-In on Cannabis Stocks?

Here’s why investors looking for top-notch cannabis stocks may want to consider Curaleaf (TSXV:CURA) right now.

Among the growth sectors in Canada that have shown astronomical potential in recent years is the cannabis sector. However, most cannabis stocks have seen marked declines of late.

That said, Curaleaf (TSXV:CURA) is a company I still think holds tremendous value as a growth play right now. Let’s dive into why this is the case.

Cannabis stocks still face a series of headwinds

It’s true that cannabis stocks provide tremendous growth potential. However, investors right now appear to feel uncomfortable with owning these high-growth stocks en masse.

There are a few reasons for this.

First, other hyper-growth stocks have simply outperformed of late. There are more speculative places to park one’s cash for gains. For speculators and traders, that’s a good thing. For those invested in cannabis stocks, perhaps less so.

Additionally, the cannabis sector has been deleveraging of late. A series of production facility closures and job cuts have hampered the growth outlook for this sector. Last week, Aurora Cannabis and Tilray announced such bearish headlines. These come as Canadian demand for cannabis hasn’t necessarily materialized as expected.

Finally, U.S. legalization hasn’t come about as many expected it would. For Curaleaf, a leading U.S. multi-state operator, this isn’t a good thing. Accordingly, all cannabis stocks, big and small, Canadian and American, have been hit from these headwinds.

But there’s hope

Recent news of the passing of the SAFE Banking Act, which will help financial companies lend and do business with cannabis-related firms, is a good thing. Additionally, movement from Chuck Schumer and other lawmakers on draft proposals of bills to legalize marijuana is a step in the right direction.

For Curaleaf, these actions are small steps in the right direction. That said, the window of opportunity with this legalization catalyst could be closing. Accordingly, investors betting on even the best cannabis companies such as Curaleaf are taking somewhat of a gamble right now.

In either case, Curaleaf has shown strong growth with the current mosaic model of various state-legalized markets. The company’s recent earnings show how strong business has been booming of late.

Curaleaf is one of the best-performing cannabis stocks out there in recent quarters. The company posted revenue growth of 170% year over year, with expected annual revenue of $1 billion this fiscal year. For a company trading at a valuation of roughly $8 billion, that price-to-sales ratio is attractive, particularly relative to its peers.

Bottom line

Cannabis stocks continue to be high-risk, high-reward bets. Investors enticed by the growth this sector provides ought to be wary of valuations. Indeed, now may not be the time to go all-in on cannabis stocks.

However, in this space, Curaleaf provides the best bang for an investor’s dollar, in my view. This is a company worth considering, for those with more aggressive risk-tolerance levels.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Cannara, Source Energy and CareRx just updated investors. See what $1,000 can buy in these Canadian stocks, plus the risks…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful

Tilray's record revenue came with declining cannabis sales and negative free cash flow, making the investment much more speculative than…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Read more »

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »